CpG-oligodeoxynucleotide is a potent adjuvant with an entamoeba histolytica gal-inhibitable lectin vaccine against amoebic liver abscess in gerbils

Infection and Immunity

Volumn 74, Issue 1, 2006, Pages 528-536

  Ivory, Catherine P A ^a   Keller, Kathy ^a   Chadee, Kris ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMEBIASIS VACCINE; CPG OLIGODEOXYNUCLEOTIDE; CYTOKINE; GALACTOSE N ACETYLGALACTOSAMINE INHIBITABLE LECTIN; GAMMA INTERFERON; IMMUNOLOGICAL ADJUVANT; INTERLEUKIN 12; INTERLEUKIN 2; LECTIN; MESSENGER RNA; PARASITE ANTIGEN; PROTOZOON ANTIBODY; UNCLASSIFIED DRUG;

ADOLESCENT; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY TITER; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DYSENTERY; ENTAMOEBA HISTOLYTICA; GERBIL; LIVER AMEBIASIS; LYMPHOCYTE PROLIFERATION; MACROPHAGE; MALE; MICROBIAL COLONIZATION; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; TH1 CELL; VACCINATION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODIES, PROTOZOAN; CPG ISLANDS; CYTOKINES; ENTAMOEBA HISTOLYTICA; GALECTINS; GERBILLINAE; LIVER ABSCESS, AMEBIC; MALE; OLIGODEOXYRIBONUCLEOTIDES; PROTOZOAN VACCINES; RNA, MESSENGER; TH1 CELLS;

EID: 29644443174     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.74.1.528-536.2006     Document Type: Article

References (48)

1. Agrawal, S., and E. R. Kandimalla. 2002. Medicinal chemistry and therapeutic potential of CpG DNA. Trends Mol. Med. 8:114-121.
2. Alignani, D., B. Maletto, M. Liscovsky, A. Ropolo, G. Moron, and M. C. Pistoresi-Palencia. 2005. Orally administered OVA/CpG-ODN induces specific mucosal and systemic immune response in young and aged mice. J. Leukoc. Biol. 77:898-905.
3. Askew, D., R. S. Chu, A. M. Krieg, and C. V. Harding. 2000. CpG DNA induces maturation of dendritic cells with distinct effects on nascent and recycling MHC-II antigen-processing mechanisms. J. Immunol. 165:6889-6895.
4. Bas, A., G. Forsberg, S. Hammarström, and M.-L. Hammarström. 2004. Utility of the housekeeping genes 18srRNA, β-actin and glyceraldehyde-3-phosphate-dehydrogenase for normalization in real-time quantitative reverse transcriptase-polymerase chain reaction analysis of gene expression in human T lymphocytes. Scand. J. Immunol. 59:566-573.
5. Behboudi, S., D. Chao, P. Klenerman, and J. Austyn. 2000. The effects of DNA containing CpG motif on dendritic cells. Immunology 99:361-366.
6. Campbell, D., D. Gaucher, and K. Chadee. 1999. Serum from Entamoeba histolytica-infected gerbils selectively suppresses T cell proliferation by inhibiting interleukin-2 production. J. Infect. Dis. 179:1495-1501.
7. Cervi, L., J. Borgonovo, M. Egea, L. Chiapello, and D. Masih. 2004. Immunization of rats against Fasciola hepatica using crude antigens conjugated with Freund's adjuvant or oligodeoxynucleotides. Vet. Immunol. Immunopathol. 97:97-104.
8. Chadee, K., and E. Meerovitch. 1984. The pathogenesis of experimentally induced amebic liver abscess in the gerbil (Meriones unguiculatus). Am. J. Pathol. 117:71-80.
9. Chadee, K., W. A. Petri, Jr., D. J. Innes, and J. I. Ravdin. 1987. Rat and human colonic mucins bind to and inhibit adherence lectin of Entamoeba histolytica. J. Clin. Investig. 80:1245-1254.
10. Cooper, C. L., H. L. Davis, M. L. Morris, S. M. Efler, A. M. Krieg, Y. Li, C. Laframboise, M. J. Al Adhami, Y. Khaliq, I. Seguin, and D. W. Cameron. 2004. Safety and immunogenicity of CPG 7909 injection as an adjuvant to Fluarix influenza vaccine. Vaccine 22:3136-3143.
11. Cornelie, S., J. Hoebeke, A. M. Schacht, B. Bertin, J. Vicogne, M. Capron, and G. Riveau. 2004. Direct evidence that toll-like receptor 9 (TLR9) functionally binds plasmid DNA by specific cytosine-phosphate-guanine motif recognition. J. Biol. Chem. 279:15124-15129.
12. Corral, R. S., and P. B. Petray. 2000. CpG DNA as a Th1-promoting adjuvant in immunization against Trypanosoma cruzi. Vaccine 19:234-242.
13. Davis, H. L., R. Weeratna, T. J. Waldschmidt, L. Tygrett, J. Schorr, and A. M. Krieg. 1998. CpG DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen. J. Immunol. 160:870-876.
14. Decker, T., F. Schneller, M. Kronschnabl, T. Dechow, G. B. Lipford, H. Wagner, and C. Peschel. 2000. Immunostimulatory CpG-oligonucleotides induce functional high affinity IL-2 receptors on B-CLL cells: costimulation with IL-2 results in a highly immunogenic phenotype. Exp. Hematol. 28:558-568.
15. Deng, J. C., T. A. Moore, M. W. Newstead, X. Zeng, A. M. Krieg, and T. J. Standiford. 2004. CpG oligodeoxynucleotides stimulate protective innate immunity against pulmonary Klebsiella infection. J. Immunol. 173:5148-5155.
16. Denis, M., and K. Chadee. 1989. Cytokine activation of murine macrophages for in vitro killing of Entamoeba histolytica trophozoites. Infect. Immun. 57:1750-1756.
17. 16a. Diamond, L. S., D. R. Harlow, and C. Cunnick. 1978. A new medium for axenic cultivation of Entamoeba histolytica and other Entamoeba. Trans. R. Soc. Trop. Med. Hyg. 72:431-432.
18. Elkins, K. L., T. R. Rhinehart-Jones, S. Stibitz, J. S. Conover, and D. M. Klinman. 1999. Bacterial DNA containing CpG motifs stimulates lymphocyte-dependent protection of mice against lethal infection with intracellular bacteria. J. Immunol. 162:2291-2298.
19. Fisher, O., R. Siman-Tov, and S. Ankri. 2004. Characterization of cytosine methylated regions and 5-cytosine DNA methyltransferase (Ehmeth) in the protozoan parasite Entamoeba histolytica. Nucleic Acids Res. 32:287-297.
20. Haque, R., I. M. Ali, R. B. Sack, B. M. Farr, G. Ramakrishnan, and W. A. Petri, Jr. 2001. Amebiasis and mucosal IgA antibody against the Entamoeba histolytica adherence lectin in Bangladeshi children. J. Infect. Dis. 183:1787-1793.
21. Haque, R., P. Duggal, I. M. Ali, M. B. Hossain, D. Mondal, R. B. Sack, B. M. Farr, T. H. Beaty, and W. A. Petri, Jr. 2002. Innate and acquired resistance to amebiasis in Bangladeshi children. J. Infect. Dis. 186:547-552.
22. Houpt, E., L. Barroso, L. Lockhart, R. Wright, C. Cramer, D. Lyerly, and W. A. Petri. 2004. Prevention of intestinal amebiasis by vaccination with the Entamoeba histolytica Gal/GalNac lectin. Vaccine 22:611-617.
23. Jones, T. R., N. Obaldia III, R. A. Gramzinski, Y. Charoenvit, N. Kolodny, S. Kitov, H. L. Davis, A. M. Krieg, and S. L. Hoffman. 1999. Synthetic oligodeoxynucleotides containing CpG motifs enhance immunogenidty of a peptide malaria vaccine in Aotus monkeys. Vaccine 17:3065-3071.
24. Karlin, S., I. Ladunga, and B. E. Blaisdell. 1994. Heterogeneity of genomes: measures and values. Proc. Natl. Acad. Sci. USA 91:12837-12841.
25. Klinman, D. M., J. Conover, and C. Coban. 1999. Repeated administration of synthetic oligodeoxynucleotides expressing CpG motifs provides long-term protection against bacterial infection. Infect. Immun. 67:5658-5663.
26. Krieg, A. M. 1999. CpG DNA: a novel immunomodulator. Trends Microbiol. 7:64-65.
27. Krieg, A. M. 2000. Immune effects and mechanisms of action of CpG motifs. Vaccine 19:618-622.
28. Krieg, A. M., L. Love-Homan, A. K. Yi, and J. T. Harty. 1998. CpG DNA induces sustained IL-12 expression in vivo and resistance to Listeria monocytogenes challenge. J. Immunol. 161:2428-2434.
29. Krieg, A. M., S. M. Efler, M. Wittpoth, M. J. Al Adhami, and H. L. Davis. 2004. Induction of systemic TH1-like innate immunity in normal volunteers following subcutaneous but not intravenous administration of CPG 7909, a synthetic B-class CpG oligodeoxynucleotide TLR9 agonist. J. Immunother. 27:460-471.
30. Li, E., A. Becker, and S. L. Stanley, Jr. 1989. Chinese hamster ovary cells deficient in N-acetylglucosaminyltransferase I activity are resistant to Entamoeba histolytica-mediated cytotoxicity. Infect. Immun. 57:8-12.
31. Lotter, H., H. Russmann, J. Heesemann, and E. Tannich. 2004. Oral vaccination with recombinant Yersinia enterocolitica expressing hybrid type III proteins protects gerbils from amebic liver abscess. Infect. Immun. 72:7318-7321.
32. Mann, B. J., B. V. Burkholder, and L. A. Lockhart. 1997. Protection in a gerbil model of amebiasis by oral immunization with Salmonella expressing the galactose/N-acetyl D-galactosamine inhibitable lectin of Entamoeba histolytica. Vaccine 15:659-663.
33. McCluskie, M. J., R. D. Weeratna, and H. L. Davis. 2000. Intranasal immunization of mice with CpG DNA induces strong systemic and mucosal responses that are influenced by other mucosal adjuvants and antigen distribution. Mol. Med. 6:867-877.
34. Moldoveanu, Z., L. Love-Homan, W. Q. Huang, and A. M. Krieg. 1998. CpG DNA, a novel immune enhancer for systemic and mucosal immunization with influenza virus. Vaccine 16:1216-1224.
35. Petri, W. A., Jr., and J. I. Ravdin. 1991. Protection of gerbils from amebic liver abscess by immunization with the galactose-specific adherence lectin of Entamoeba histolytica. Infect. Immun. 59:97-101.
36. Petri, W. A., Jr., J. Broman, G. Healy, T. Quinn, and J. I. Ravdin. 1989. Antigenic stability and immunodominance of the Gal/GalNAc adherence lectin of Entamoeba histolytica. Am. J. Med. Sci. 297:163-165.
37. Petri, W. A., Jr., M. D. Chapman, T. Snodgrass, B. J. Mann, J. Broman, and J. I. Ravdin. 1989. Subunit structure of the galactose and N-acetyl-D-galactosamine-inhibitable adherence lectin of Entamoeba histolytica. J. Biol. Chem. 264:3007-3012.
38. Petri, W. A., Jr., R. D. Smith, P. H. Schlesinger, C. F. Murphy, and J. I. Ravdin. 1987. Isolation of the galactose-binding lectin that mediates the in vitro adherence of Entamoeba histolytica. J. Clin. Investig. 80:1238-1244.
39. Ravdin, J. I., C. F. Murphy, R. A. Salata, R. L. Guerrant, and E. L. Hewlett. 1985. N-acetyl-D-galactosamine-inhibitable adherence lectin of Entamoeba histolytica. I. Partial purification and relation to amoebic virulence in vitro. J. Infect. Dis. 151:804-815.
40. Schain, D. C., R. A. Salata, and J. I. Ravdin. 1992. Human T-lymphocyte proliferation, lymphokine production, and amebicidal activity elicited by the galactose-inhibitable adherence protein of Entamoeba histolytica. Infect. Immun. 60:2143-2146.
41. Schain, D. C., R. A. Salata, and J. I. Ravdin. 1995. Development of amebicidal cell-mediated immunity in gerbils (Meriones unguiculatus) immunized with the galactose-inhibitable adherence lectin of Entamoeba histolytica. J. Parasitol. 81:563-568.
42. Séguin, R., B. J. Mann, K. Keller, and K. Chadee. 1997. The tumor necrosis factor alpha-stimulating region of galactose-inhibitable lectin of Entamoeba histoliytica activates gamma interferon-primed macrophages for amebicidal activity mediated by nitric oxide. Infect. Immun. 65:2522-2527.
43. Seydel, K. B., S. J. Smith, and S. L. Stanley, Jr. 2000. Innate immunity to amebic liver abscess is dependent on gamma interferon and nitric oxide in a murine model of disease. Infect. Immun. 68:400-402.
44. Soong, C. J., K. C. Kain, M. Abd-Alla, T. F. Jackson, and J. I. Ravdin. 1995. A recombinant cysteine-rich section of the Entamoeba histolytica galactose-inhibitable lectin is efficacious as a subunit vaccine in the gerbil model of amebic liver abscess. J. Infect. Dis. 171:645-651.
45. Stacey, K. J., and J. M. Blackwell. 1999. Immunostimulatory DNA as an adjuvant in vaccination against Leishmania major. Infect Immun. 67:3719-3726.
46. Weeratna, R. D., M. J. McCluskie, Y. Xu, and H. L. Davis. 2000. CpG DNA induces stronger immune responses with less toxicity than other adjuvants. Vaccine 18:1755-1762.
47. World Health Organization. 1997. Amoebiasis. Wkly. Epidemiol. Rec. 72:97-99.
48. Zhang, T., and S. L. Stanley, Jr. 1994. Protection of gerbils from amebic liver abscess by immunization with a recombinant protein derived from the 170-kilodalton surface adhesin of Entamoeba histolytica. Infect. Immun. 62:2605-2608.